Related references
Note: Only part of the references are listed.CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni Maalej et al.
MOLECULAR CANCER (2023)
Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies
Jue Zhang et al.
STEM CELL REPORTS (2023)
Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
Alok K. Mishra et al.
VACCINES (2023)
CD19 CAR T cell therapy effective for systemic lupus erythematosus
J. Gelfand
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)
M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors
Yi Huo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
Bastian Kruse et al.
NATURE (2023)
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh et al.
NATURE (2023)
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia
Mayumi Sugita et al.
CELL DEATH & DISEASE (2023)
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Yun Chang et al.
NATURE COMMUNICATIONS (2023)
Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy
Lin Gao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2023)
Surficial nano-deposition locoregionally yielding bactericidal super CAR-macrophages expedites periprosthetic osseointegration
Ziyang Li et al.
SCIENCE ADVANCES (2023)
Metabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng et al.
SCIENCE IMMUNOLOGY (2023)
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha et al.
VACCINES (2023)
Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy
Zhenmei Yang et al.
JOURNAL OF CONTROLLED RELEASE (2023)
The application of HER2 and CD47 CAR-macrophage in ovarian cancer
Yizhao Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
Xuhui Dong et al.
BRITISH JOURNAL OF CANCER (2023)
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Senbo Liu et al.
CELL DEATH & DISEASE (2023)
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors
Xudong Wang et al.
NATURE COMMUNICATIONS (2023)
Photoresponsive Vaccine-Like CAR-M System with High-Efficiency Central Immune Regulation for Inflammation-Related Depression
Yu Liu et al.
ADVANCED MATERIALS (2022)
CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie et al.
GUT (2022)
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Alexander Dimitri et al.
MOLECULAR CANCER (2022)
Ex Vivo Generation of CAR Macrophages from Hematopoietic Stem and Progenitor Cells for Use in Cancer Therapy
Daniela Paasch et al.
CELLS (2022)
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
Maoxuan Liu et al.
CELLS (2022)
The complex role of tumor-infiltrating macrophages
Anthos Christofides et al.
NATURE IMMUNOLOGY (2022)
Macrophages as tools and targets in cancer therapy
Alberto Mantovani et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy
Chen Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
Yun Chang et al.
CELL REPORTS (2022)
Hypoxia-inducible lentiviral gene expression in engineered human macrophages
Harrison K. Chinn et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Tobias Zeller et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeted nanoparticles modify neutrophil function in vivo
Sandra Vols et al.
FRONTIERS IN IMMUNOLOGY (2022)
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Andreas Mackensen et al.
NATURE MEDICINE (2022)
A PHASE 1, FIRST IN HUMAN (FIH) STUDY OF AUTOLOGOUS MACROPHAGES CONTAINING AN ANTIHER2 CHIMERIC ANTIGEN RECEPTOR (CAR) IN PARTICIPANTS WITH HER2 OVEREXPRESSING SOLID TUMORS
Kim Reiss et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
M-L Schubert et al.
ANNALS OF ONCOLOGY (2021)
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson et al.
CANCER RESEARCH (2021)
Chimeric antigen receptor-modified macrophages trigger systemic anti-tumour immunity
Zhiyuan Niu et al.
JOURNAL OF PATHOLOGY (2021)
Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease
Amit A. Patel et al.
IMMUNOLOGY (2021)
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Christopher Sloas et al.
FRONTIERS IN IMMUNOLOGY (2021)
Recent Advances in Macrophage-Mediated Drug Delivery Systems
Tiantian Liang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO
Khosrow Kashfi et al.
CELLS (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer Therapy
Mikyung Kang et al.
ADVANCED MATERIALS (2021)
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
Rosalynd Upton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
CAR Macrophages for SARS-CoV-2 Immunotherapy
Wenyan Fu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions
Irina Lyadova et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Neutrophils as emerging therapeutic targets
Tamas Nemeth et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling
Lingfeng Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Systemic Reprogramming of Monocytes in Cancer
Mate Kiss et al.
FRONTIERS IN ONCOLOGY (2020)
CAR MACROPHAGES (CAR-M) ELICIT A SYSTEMIC ANTITUMOR IMMUNE RESPONSE AND SYNERGIZE WITH PD1 BLOCKADE IN IMMUNOCOMPETENT MOUSE MODELS OF HER2+SOLID TUMORS
Stefano Pierini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma
Jennifer L. Gardell et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
Katherine J. Brempelis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
Li Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Antibody-secreting macrophages generated using CpG-free plasmid eliminate tumor cells through antibody-dependent cellular phagocytosis
Eun Bi Cha et al.
BMB REPORTS (2020)
Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment
Yuting Zhang et al.
CANCER BIOLOGY & MEDICINE (2020)
Neutrophil plasticity in the tumor microenvironment
Morgan A. Giese et al.
BLOOD (2019)
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
Cory D. Sago et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
Nadege Bercovici et al.
FRONTIERS IN IMMUNOLOGY (2019)
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
Wenlong Zhang et al.
BRITISH JOURNAL OF CANCER (2019)
Safety profile of autologous macrophage therapy for liver cirrhosis
Francesca Moroni et al.
NATURE MEDICINE (2019)
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
Julio C. Chavez et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M. Nywening et al.
GUT (2018)
CAR-T cells: the long and winding road to solid tumors
Maria Michela D'Aloia et al.
CELL DEATH & DISEASE (2018)
Chimeric antigen receptors that trigger phagocytosis
Meghan A. Morrissey et al.
ELIFE (2018)
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Carlos Rosales
FRONTIERS IN PHYSIOLOGY (2018)
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape
Carl DeSelm et al.
MOLECULAR THERAPY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy
Liang Pang et al.
DRUG DELIVERY (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
Amit A. Patel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro
Hiromi Shiratori et al.
MOLECULAR IMMUNOLOGY (2017)
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Donnele Daley et al.
NATURE MEDICINE (2017)
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
Jingwei Xue et al.
NATURE NANOTECHNOLOGY (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy
Ming Yang et al.
CANCER BIOLOGY & THERAPY (2017)
Granulocyte transfusions: A concise review for practitioners
Juan Gea-Banacloche
CYTOTHERAPY (2017)
Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives
Julio Lahoz-Beneytez et al.
BLOOD (2016)
Macrophage-based cell therapies: The long and winding road
Simon Lee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim et al.
MEDIATORS OF INFLAMMATION (2016)
Chimeric antigen receptor T-cell therapy for solid tumors
Kheng Newick et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Ali Roghanian et al.
CANCER CELL (2015)
Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer
Jijun Fu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury
Simonetta Papa et al.
JOURNAL OF CONTROLLED RELEASE (2014)
From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation
Paola Italiani et al.
FRONTIERS IN IMMUNOLOGY (2014)
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Jun Yan et al.
ONCOIMMUNOLOGY (2014)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
How Samhd1 changes our view of viral restriction
Nadine Laguette et al.
TRENDS IN IMMUNOLOGY (2012)
Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy
S. Senju et al.
GENE THERAPY (2011)
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Kasia Hrecka et al.
NATURE (2011)
Biocompatibility of implants: lymphocyte/macrophage interactions
James M. Anderson et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy
Gerben J. van der Bij et al.
JOURNAL OF HEPATOLOGY (2010)
Neutrophil function in inflammation and inflammatory diseases
Helen L. Wright et al.
RHEUMATOLOGY (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
Michele De Palma et al.
CANCER CELL (2008)
Macrophage activation by endogenous danger signals
X. Zhang et al.
JOURNAL OF PATHOLOGY (2008)
Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo
A Biglari et al.
GENE THERAPY (2006)
Transduction of nondividing human macrophages with gammaretrovirus-derived vectors
L Jarrosson-Wuilleme et al.
JOURNAL OF VIROLOGY (2006)
Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells
Z Parveen et al.
NATURE BIOTECHNOLOGY (2000)